Aryl hydrocarbon receptor activation synergistically induces lipopolysaccharide-mediated expression of proinflammatory chemokine (c-c motif) ligand 20

Toxicological Sciences

Volumn 148, Issue 1, 2015, Pages 229-240

  Lahoti, Tejas S ^a   Boyer, Jacob A ^a   Kusnadi, Ann ^a   Muku, Gulsum E ^a   Murray, Iain A ^a   Perdew, Gary H ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

AHR agonists; Aryl hydrocarbon receptor; chemokine; chemokine (c c motif); ligand 20; lipopolysaccharide; macrophages

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; HETERODIMER; HISTONE DEACETYLASE 1; HYPOXIA INDUCIBLE FACTOR 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; AHR PROTEIN, MOUSE; ARNT PROTEIN, MOUSE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CARBAZOLE DERIVATIVE; CCL20 PROTEIN, MOUSE; HDAC1 PROTEIN, MOUSE; INDOLO(3,2-B)CARBAZOLE; LIGAND; POLLUTANT; POLYCHLORINATED DIBENZODIOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; MACROPHAGE CULTURE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; ACTIVE TRANSPORT; AGONISTS; ALLELE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CROSS BREEDING; CYTOLOGY; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; KERATINOCYTE; KNOCKOUT MOUSE; METABOLISM; MUTANT MOUSE STRAIN; POLLUTANT; TOXICITY; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ALLELES; ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBAZOLES; CELLS, CULTURED; CHEMOKINE CCL20; CROSSES, GENETIC; DRUG SYNERGISM; ENVIRONMENTAL POLLUTANTS; HISTONE DEACETYLASE 1; KERATINOCYTES; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; POLYCHLORINATED DIBENZODIOXINS; PROMOTER REGIONS, GENETIC; RECEPTORS, ARYL HYDROCARBON; UP-REGULATION;

EID: 84947718648     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv178     Document Type: Article

References (62)

1. Apetoh, L., Quintana, F. J., Pot, C., Joller, N., Xiao, S., Kumar, D., Burns, E. J., Sherr, D. H., Weiner, H. L., and Kuchroo, V. K. (2010). The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861.
2. Bain, C. C., Scott, C. L., Uronen-Hansson, H., Gudjonsson, S., Jansson, O., Grip, O., Guilliams, M., Malissen, B., Agace, W. W., and Mowat, A. M. (2013). Resident and pro-inflammatory macrophages in the colon represent alternative contextdependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6, 498-510.
3. Beamer, C. A., Seaver, B. P., and Shepherd, D. M. (2012). Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis. Toxicol. Sci. 126, 554-568.
4. Beischlag, T. V., Luis Morales, J., Hollingshead, B. D., and Perdew, G. H. (2008). The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene Expr. 18, 207-250.
5. Bessede, A., Gargaro, M., Pallotta, M. T., Matino, D., Servillo, G., Brunacci, C., Bicciato, S., Mazza, E. M., Macchiarulo, A., Vacca, C., et al. (2014). Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511, 184-190.
6. Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., and Bradfield, C. A. (2008). Abnormal liver development and resistance to 2, 3, 7, 8-tetrachlorodibenzop-dioxin toxicity in mice carrying a mutation in the DNAbinding domain of the aryl hydrocarbon receptor. Toxicol. Sci. 106, 83-92.
7. Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., and Bradfield, C. A. (2003). Resistance to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J. Biol. Chem. 278, 17767-17774.
8. Comerford, I., Bunting, M., Fenix, K., Haylock-Jacobs, S., Litchfield, W., Harata-Lee, Y., Turvey, M., Brazzatti, J., Gregor, C., Nguyen, P., et al. (2010). An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: A chemokine axis balancing immunological tolerance and inflammation in autoimmune disease. Bioessays 32, 1067-1076.
9. Comerford, I., and McColl, S. R. (2011). Mini-review series: Focus on chemokines. Immunol. Cell Biol. 89, 183-184.
10. Crane-Godreau, M. A., and Wira, C. R. (2005). CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys. Infect. Immun. 73, 476-484.
11. DiNatale, B. C., Schroeder, J. C., Francey, L. J., Kusnadi, A., and Perdew, G. H. (2010). Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling. J. Biol. Chem. 285, 24388-24397.
12. Dlugosz, A. A., Glick, A. B., Tennenbaum, T., Weinberg, W. C., and Yuspa, S. H. (1995). Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol. 254, 3-20.
13. Flaveny, C. A., Murray, I. A., Chiaro, C. R., and Perdew, G. H. (2009). Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice. Mol. Pharmacol. 75, 1412-1420.
14. Fukumoto, S., Toshimitsu, T., Matsuoka, S., Maruyama, A., Oh-Oka, K., Takamura, T., Nakamura, Y., Ishimaru, K., Fujii-Kuriyama, Y., Ikegami, S., et al. (2014). Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis. Immunol. Cell Biol. 92, 460-465.
15. Furumatsu, K., Nishiumi, S., Kawano, Y., Ooi, M., Yoshie, T., Shiomi, Y., Kutsumi, H., Ashida, H., Fujii-Kuriyama, Y., Azuma, T., et al. (2011). A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig. Dis. Sci. 56, 2532-2544.
16. Harper, E. G., Guo, C., Rizzo, H., Lillis, J. V., Kurtz, S. E., Skorcheva, I., Purdy, D., Fitch, E., Iordanov, M., and Blauvelt, A. (2009). Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis. J. Invest. Dermatol. 129, 2175-2183.
17. Hausmann, M., Zeitler, C., Weber, A., Krebs, M., Kellermeier, S., Rosenstiel, P., de Valliere, C., Kosovac, K., Fried, M., Holler, E., et al. (2012). MIP-3alpha expression in macrophages is NOD dependent. Digestion 85, 192-201.
18. Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Yamaguchi, T., Nomura, T., Ito, H., Nakamura, T., et al. (2007). Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803-2812.
19. Hosokawa, Y., Hosokawa, I., Ozaki, K., Nakae, H., and Matsuo, T. (2005). Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin. Exp. Immunol. 142, 285-291.
20. Ito, T., Carson, W. F., 4th, Cavassani, K. A., Connett, J. M., and Kunkel, S. L. (2011). CCR6 as a mediator of immunity in the lung and gut. Exp. Cell Res. 317, 613-619.
21. Joiakim, A., Mathieu, P. A., Elliott, A. A., and Reiners, J. J., Jr. (2004). Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: A process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome. Mol. Pharmacol. 66, 936-947.
22. Kanda, N., Shibata, S., Tada, Y., Nashiro, K., Tamaki, K., and Watanabe, S. (2009). Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur. J. Immunol. 39, 996-1006.
23. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors. Nat. Immunol. 11, 373-384.
24. Kennedy-Crispin, M., Billick, E., Mitsui, H., Gulati, N., Fujita, H., Gilleaudeau, P., Sullivan-Whalen, M., Johnson-Huang, L. M., Suarez-Farinas, M., and Krueger, J. G. (2012). Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. J. Invest. Dermatol. 132, 105-113.
25. Kimura, A., Naka, T., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii-Kuriyama, Y., and Kishimoto, T. (2009). Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 206, 2027-2035.
26. Kiss, E. A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., and Diefenbach, A. (2011). Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565.
27. Kobayashi, S., Okamoto, H., Iwamoto, T., Toyama, Y., Tomatsu, T., Yamanaka, H., and Momohara, S. (2008). A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 47, 1317-1322.
28. Lahoti, T. S., John, K., Hughes, J. M., Kusnadi, A., Murray, I. A., Krishnegowda, G., Amin, S., and Perdew, G. H. (2013). Aryl hydrocarbon receptor antagonism mitigates cytokinemediated inflammatory signalling in primary human fibroblast-like synoviocytes. Ann. Rheum. Dis. 72, 1708-1716.
29. Le Borgne, M., Etchart, N., Goubier, A., Lira, S. A., Sirard, J. C., van Rooijen, N., Caux, C., Ait-Yahia, S., Vicari, A., Kaiserlian, D., et al. (2006). Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24, 191-201.
30. Li, Q., Laumonnier, Y., Syrovets, T., and Simmet, T. (2013). Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages. Acta Biochim. Biophys. Sin. (Shanghai) 45, 593-600.
31. Lusska, A., Wu, L., and Whitlock, J. P., Jr. (1992). Superinduction of CYP1A1 transcription by cycloheximide. Role of the DNA binding site for the liganded Ah receptor. J. Biol. Chem. 267, 15146-15151.
32. Luster, A. D. (2002). The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14, 129-135.
33. Ma, Q., and Baldwin, K. T. (2002). A cycloheximide-sensitive factor regulates TCDD-induced degradation of the aryl hydrocarbon receptor. Chemosphere 46, 1491-1500.
34. Magiatis, P., Pappas, P., Gaitanis, G., Mexia, N., Melliou, E., Galanou, M., Vlachos, C., Stathopoulou, K., Skaltsounis, A. L., Marselos, M., et al. (2013). Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. J. Invest. Dermatol. 133, 2023-2030.
35. Masuda, K., Kimura, A., Hanieh, H., Nguyen, N. T., Nakahama, T., Chinen, I., Otoyo, Y., Murotani, T., Yamatodani, A., and Kishimoto, T. (2011). Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages. Int. Immunol. 23, 637-645.
36. Murdoch, C., and Finn, A. (2000). Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032-3043.
37. Murray, I. A., Krishnegowda, G., DiNatale, B. C., Flaveny, C., Chiaro, C., Lin, J. M., Sharma, A. K., Amin, S., and Perdew, G. H. (2010a). Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits antiinflammatory properties. Chem. Res. Toxicol. 23, 955-966.
38. Murray, I. A., Morales, J. L., Flaveny, C. A., DiNatale, B. C., Chiaro, C., Gowdahalli, K., Amin, S., and Perdew, G. H. (2010b). Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity. Mol. Pharmacol. 77, 247-254.
39. Nandi, B., Pai, C., Huang, Q., Prabhala, R. H., Munshi, N. C., and Gold, J. S. (2014). CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS One 9, e97566.
40. Petrulis, J. R., and Perdew, G. H. (2002). The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem. Biol. Interact. 141, 25-40.
41. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., and Weiner, H. L. (2008). Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71.
42. Quintana, F. J., and Sherr, D. H. (2013). Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol. Rev. 65, 1148-1161.
43. Ren, H., Teng, Y., Tan, B., Zhang, X., Jiang, W., Liu, M., Jiang, W., Du, B., and Qian, M. (2014). Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular ATP release. Infect. Immun. 82, 5076-5085.
44. Rubie, C., Frick, V. O., Ghadjar, P., Wagner, M., Grimm, H., Vicinus, B., Justinger, C., Graeber, S., and Schilling, M. K. (2010). CCL20/CCR6 expression profile in pancreatic cancer. J. Transl. Med. 8, 45.
45. Scapini, P., Crepaldi, L., Pinardi, C., Calzetti, F., and Cassatella, M. A. (2002). CCL20/macrophage inflammatory protein-3alpha production in LPS-stimulated neutrophils is enhanced by the chemoattractant formyl-methionyl-leucyl-phenylalanine and IFN-gamma through independent mechanisms. Eur. J. Immunol. 32, 3515-3524.
46. Schutyser, E., Struyf, S., Menten, P., Lenaerts, J. P., Conings, R., Put, W., Wuyts, A., Proost, P., and Van Damme, J. (2000). Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J. Immunol. 165, 4470-4477.
47. Schutyser, E., Struyf, S., and Van Damme, J. (2003). The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409-426.
48. Sekine, H., Mimura, J., Oshima, M., Okawa, H., Kanno, J., Igarashi, K., Gonzalez, F. J., Ikuta, T., Kawajiri, K., and Fujii-Kuriyama, Y. (2009). Hypersensitivity of aryl hydrocarbon receptordeficient mice to lipopolysaccharide-induced septic shock. Mol. Cell. Biol. 29, 6391-6400.
49. Shindo, S., Hosokawa, Y., Hosokawa, I., Ozaki, K., and Matsuo, T. (2014). Genipin inhibits IL-1beta-induced CCL20 and IL-6 production from human periodontal ligament cells. Cell. Physiol. Biochem. 33, 357-364.
50. Sierro, F., Dubois, B., Coste, A., Kaiserlian, D., Kraehenbuhl, J. P., and Sirard, J. C. (2001). Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 98, 13722-13727.
51. Singh, S. S., Hord, N. G., and Perdew, G. H. (1996). Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. Arch. Biochem. Biophys. 329, 47-55.
52. Smith, P. D., Smythies, L. E., Mosteller-Barnum, M., Sibley, D. A., Russell, M. W., Merger, M., Sellers, M. T., Orenstein, J. M., Shimada, T., Graham, M. F., et al. (2001). Intestinal macrophages lack CD14 and CD89 and consequently are downregulated for LPS-and IgA-mediated activities. J. Immunol. 167, 2651-2656.
53. Stange, J., and Veldhoen, M. (2013). The aryl hydrocarbon receptor in innate T cell immunity. Semin. Immunopathol. 35, 645-655.
54. Tauchi, M., Hida, A., Negishi, T., Katsuoka, F., Noda, S., Mimura, J., Hosoya, T., Yanaka, A., Aburatani, H., Fujii-Kuriyama, Y., et al. (2005). Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol. Cell. Biol. 25, 9360-9368.
55. van den Bogaard, E. H., Podolsky, M. A., Smits, J. P., Cui, X., John, C., Gowda, K., Desai, D., Amin, S. G., Schalkwijk, J., Perdew, G. H., et al. (2015). Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation. J. Invest. Dermatol. 135, 1320-1328.
56. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C., and Stockinger, B. (2008). The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109.
57. Vogel, C. F., Khan, E. M., Leung, P. S., Gershwin, M. E., Chang, W. L., Wu, D., Haarmann-Stemmann, T., Hoffmann, A., and Denison, M. S. (2014). Cross-talk between aryl hydrocarbon receptor and the inflammatory response: A role for nuclear factor-kappaB. J. Biol. Chem. 289, 1866-1875.
58. Vogel, C. F., Wu, D., Goth, S. R., Baek, J., Lollies, A., Domhardt, R., Grindel, A., and Pessah, I. N. (2013). Aryl hydrocarbon receptor signaling regulates NF-kappaB RelB activation during dendritic-cell differentiation. Immunol. Cell Biol. 91, 568-575.
59. Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin-Orozco, N., Kang, H. S., Ma, L., Panopoulos, A. D., et al. (2008). CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181, 8391-8401.
60. Ye, J., and Young, H. A. (1997). Negative regulation of cytokine gene transcription. FASEB J. 11, 825-833.
61. Zhang, X., Goncalves, R., and Mosser, D. M. (2008). The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit 14 1.
62. Zlotnik, A., and Yoshie, O. (2000). Chemokines: A new classification system and their role in immunity. Immunity 12, 121-127.